Trust Company’s Precigen PGEN Stock Holding History

Trust Company’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-428	Closed	-$5K	–	371
2017 Q4	$5K	Buy	+428	New	+$6.37K	﹤0.01%	327

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Trust Company's PGEN Position: Q1 2018 in Review

Trust Company sold out of Precigen (PGEN) in Q1 2018, closing a stake of 428 shares — an estimated $5K sold.

Trust Company first reported a position in PGEN in Q4 2017 and held it in 1 quarter. The position peaked at $5K in Q4 2017. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2018.

Trust Company reported no remaining Precigen position as of Q1 2018 after selling out during the quarter.
Trust Company sold 428 Precigen shares in Q1 2018, an estimated $5K.
Trust Company first reported a position in Precigen in Q4 2017 and held it in 1 quarter.
Trust Company's Precigen position peaked at $5K in Q4 2017.
166 funds tracked by Wall St. Rank held Precigen as of Q1 2018.

Based on Trust Company's 13F filing for Q1 2018, filed 9 Apr 2018.